Lee T, Roberts D
Cancer Res. 1984 Jul;44(7):2986-90.
The flux of teniposide (VM-26) across the cell membrane was compared for L1210 cells, nine VM-26-resistant L1210 sublines, and three partially revertant lines. The nine resistant sublines were maintained in medium with VM-26. A "zero-time," temperature-independent binding of VM-26 to cells, attributable to adsorption on the cell membrane or to solvation in the membrane, varied independently of the sensitivity of cell lines to the drug as measured by the extracellular concentration of drug required to inhibit growth of a subline by 50% at the end of 24 hr (IC50). The IC50 values varied from 22 nM VM-26 for parental cells to 45 microM VM-26 for the most resistant subline. After subtraction of the zero-time values, the initial rates of influx for VM-26 (extracellular concentration, 20.5 microM) and the apparent equilibrium constants for the flux of drug across the cell membrane correlated inversely with the logarithm of the IC50 values. Cellular steady-state levels of VM-26, initial rates of efflux of the drug, and cellular levels of nondiffusible drug varied independently of the IC50 values but in relation to each other. The efflux of VM-26 from the sublines was faster than from the parental cells at both 4 degrees and at 37 degrees. We conclude that resistance of L1210 cells to VM-26 is associated with changes in the flux of the drug across the cell membrane.
比较了替尼泊苷(VM - 26)在L1210细胞、9个VM - 26耐药的L1210亚系细胞以及3个部分回复系细胞中的跨细胞膜通量。9个耐药亚系细胞培养于含有VM - 26的培养基中。VM - 26与细胞的“零时”温度无关结合,这归因于其吸附在细胞膜上或在膜中的溶剂化作用,与细胞系对药物的敏感性无关,细胞系对药物的敏感性通过在24小时末抑制亚系细胞生长50%所需的细胞外药物浓度(IC50)来衡量。IC50值范围从亲代细胞的22 nM VM - 26到最耐药亚系细胞的45 μM VM - 26。减去零时值后,VM - 26的初始内流速率(细胞外浓度为20.5 μM)以及药物跨细胞膜通量的表观平衡常数与IC50值的对数呈负相关。VM - 26的细胞稳态水平、药物的初始外排速率以及非扩散性药物的细胞水平与IC50值无关,但彼此相关。在4℃和37℃时,亚系细胞中VM - 26的外排都比亲代细胞快。我们得出结论,L1210细胞对VM - 26的耐药性与药物跨细胞膜通量的变化有关。